Copyright Reports & Markets. All rights reserved.

Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Monoclonal Antibodies
      • 1.4.3 Small Molecules
      • 1.4.4 Small Molecule Drug Conjugates
    • 1.5 Market by Application
      • 1.5.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application (2014-2025)
      • 1.5.2 Lymphoma
      • 1.5.3 Melanoma
      • 1.5.4 Multiple Myeloma
      • 1.5.5 Breast Cancer
      • 1.5.6 Prostate Cancer
      • 1.5.7 Other Cancers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Small Molecule Targeted Cancer Therapy Market Size
    • 2.2 Small Molecule Targeted Cancer Therapy Growth Trends by Regions
      • 2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Small Molecule Targeted Cancer Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Small Molecule Targeted Cancer Therapy Market Size by Manufacturers
      • 3.1.1 Global Small Molecule Targeted Cancer Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Small Molecule Targeted Cancer Therapy Key Players Head office and Area Served
    • 3.3 Key Players Small Molecule Targeted Cancer Therapy Product/Solution/Service
    • 3.4 Date of Enter into Small Molecule Targeted Cancer Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Small Molecule Targeted Cancer Therapy Market Size by Type (2014-2019)
    • 4.2 Global Small Molecule Targeted Cancer Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 5.2 Small Molecule Targeted Cancer Therapy Key Players in United States
    • 5.3 United States Small Molecule Targeted Cancer Therapy Market Size by Type
    • 5.4 United States Small Molecule Targeted Cancer Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 6.2 Small Molecule Targeted Cancer Therapy Key Players in Europe
    • 6.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Type
    • 6.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Application

    7 China

    • 7.1 China Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 7.2 Small Molecule Targeted Cancer Therapy Key Players in China
    • 7.3 China Small Molecule Targeted Cancer Therapy Market Size by Type
    • 7.4 China Small Molecule Targeted Cancer Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 8.2 Small Molecule Targeted Cancer Therapy Key Players in Japan
    • 8.3 Japan Small Molecule Targeted Cancer Therapy Market Size by Type
    • 8.4 Japan Small Molecule Targeted Cancer Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 9.2 Small Molecule Targeted Cancer Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type
    • 9.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application

    10 India

    • 10.1 India Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 10.2 Small Molecule Targeted Cancer Therapy Key Players in India
    • 10.3 India Small Molecule Targeted Cancer Therapy Market Size by Type
    • 10.4 India Small Molecule Targeted Cancer Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Small Molecule Targeted Cancer Therapy Market Size (2014-2019)
    • 11.2 Small Molecule Targeted Cancer Therapy Key Players in Central & South America
    • 11.3 Central & South America Small Molecule Targeted Cancer Therapy Market Size by Type
    • 11.4 Central & South America Small Molecule Targeted Cancer Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 OncoGenex Pharmaceuticals, Inc.
      • 12.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
    • 12.2 Cytokinetics Inc.
      • 12.2.1 Cytokinetics Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.2.5 Cytokinetics Inc. Recent Development
    • 12.3 Hospira Inc.
      • 12.3.1 Hospira Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.3.5 Hospira Inc. Recent Development
    • 12.4 GlaxoSmithKline plc
      • 12.4.1 GlaxoSmithKline plc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.4.5 GlaxoSmithKline plc Recent Development
    • 12.5 Boehringer Ingelheim GmbH
      • 12.5.1 Boehringer Ingelheim GmbH Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.5.5 Boehringer Ingelheim GmbH Recent Development
    • 12.6 Bayer HealthCare AG
      • 12.6.1 Bayer HealthCare AG Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.6.5 Bayer HealthCare AG Recent Development
    • 12.7 Abbott Laboratories
      • 12.7.1 Abbott Laboratories Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Small Molecule Targeted Cancer Therapy Introduction
      • 12.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2014-2019)
      • 12.7.5 Abbott Laboratories Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Small Molecule Targeted Cancer Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Molecule Targeted Cancer Therapy development in United States, Europe and China.

      The key players covered in this study
      OncoGenex Pharmaceuticals, Inc.
      Cytokinetics Inc.
      Hospira Inc.
      GlaxoSmithKline plc
      Boehringer Ingelheim GmbH
      Bayer HealthCare AG
      Abbott Laboratories
      ...

      Market segment by Type, the product can be split into
      Monoclonal Antibodies
      Small Molecules
      Small Molecule Drug Conjugates

      Market segment by Application, split into
      Lymphoma
      Melanoma
      Multiple Myeloma
      Breast Cancer
      Prostate Cancer
      Other Cancers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Small Molecule Targeted Cancer Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Small Molecule Targeted Cancer Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now